InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Broom Colin MD, 董事. Director active across 1 company, notably Nabriva Therapeutics plc. Aggregated, 3 reports have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €2k. Activity tracked since 28 July 2021. The latest transaction was filed on 2 August 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Broom Colin MD is a Board Member at Nabriva Therapeutics plc. In this role, he brings his expertise in biotechnology and healthcare, contributing to the strategic direction of the company. His experience in pharmaceutical research and development is a valuable asset to the board, guiding decisions related to innovation and regulatory compliance.